Kctd13 deletion reduces synaptic transmission via increased RhoA

Experimental evidence that global Kctd13 reduction leads to increased RhoAlevels that reduce synaptic transmission, implicating RhoAas a potential therapeutic target for neuropsychiatric disorders associated with copy-number variants that include KCTD13.